The article demonstrates the merit of having a proper plan about how you are going to involve patients and parents: the way you are going to find people; the need for a structure for the discussions; how to capture the contributions; and to describe the differences and impact these have made. This type of structural clarity is missing from much of the writing about PPI.
First of all, the reach was by social media rather than handpicking a few select individuals to sit on a committee or attend a discussion group. Although many of the respondents were known to the researchers, this openness gave opportunities for others to join and probably helped raise awareness. This shows the extent to finding different means of PPI (Inclusiveness and Working Together).
Using video conferencing means that people can fit involvement into their lives rather than always travel to a meeting. The fact that the team had a contingencies to enable a telephone conference element and contribution by email can be viewed as inclusive and helpful communication.
The structure for the discussion of Importance, Value, Outcomes and Advice could be outlined a little stronger in the article as it offers a useful framework for other to follow and adapt.
Similarly the clustering of the issues into study specific themes are again helpful guides.
The real power of this article lies in the examples of how this involvement changed the actual design of the study in a fundamental manner -ie the randomise method (Impact). The clarity with which the group recommended the use of clinical data was also interesting as it is an issue worrying many researchers.
The recording and reporting (Communications and Impact) of the dialogue between the team and those affected by paediatric febrile neutropenia is well composed offering a mix of quotes, comment and analysis.
The description of being 'in a cupboard' perfectly captures the line that this exercise brought about a 'deeper understanding'.
Finally, I like the fact that the group have shown a willingness to continue to be involved and that they will be included on the Trial Steering Group (Governance). The authors should be encouraged to continue writing about how the patient voice is helping to shape and influence this work. It will be interesting to see how both the patients and team are supported and what they feel they have learned from the experience over time (Support and Learning).
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GENERAL COMMENTS
This is a really interesting article which I think could make a worthwhile contribution to the literature on patient and public involvement in health and social care as well as paediatric oncology. As the former is my area of expertise rather than the latter the following comments are focused on this submission as an article on PPI.
I think the article needs to locate this work in relation to the PPI literature and particularly the literature on children and young people's involvement e.g. why the research team wanted to do PPI, evidence on benefits and good practice. Some recent references are included below which may be useful + I would suggest following the GRIPP2 guidance as this is now the accepted standard on reporting PPI.
The article reports clearly how the public involvement group was set up and run but I think does so fairly uncritically. Some reflection on the cons as well as the pros of the approach taken and emerging learning would be helpful. as above more discussion on the pros and cons of, for example, involving parents and young people in the same group + video as opposed to face to face meetings. Much of the existing evidence on young people's involvement seems to say that face-toface is better so I'm interested in why the authors found this not to be the case with this project and whether they this approach might potentially exclude some, while enabling the involvement of others?
The authors say that 'the participants volunteered their time and were not paid' but NIHR INVOLVE guidance is that public contributors should be paid for their time. This should probably be mentioned or briefly discussed.
'A patient/public engagement group of experts through experience in the development of a study' -could this wording be clarified/simplified? Also in this paragraph explain why ethical review wasn't required for readers who may be unfamiliar with the NIHR INVOLVE/HTA guidance on this. 'Study-specific themes': I agree that 'PPI is important in modifying....presumptions and beliefs' and this would be a good point to draw in some of the literature. Similarly where the authors state that 'this seems to speak of a greater public awareness being required'.
I was interested in knowing more about plans for PPI when the trial is underway, if and how the group informed these plans and any ongoing involvement in the study (e.g. as coapplicants). This is only mentioned in passing in the final sentence but I think merits further discussion. Comments to the Author Please note: I have used some of the terms (in brackets) from the National PPI Standards that the authors may wish to consider referencing at times in the document or in future papers. This work also reflects Kristina Staley's report that talks about PPI making a difference to 'research' and 'people'.
Response summary:
We would like to thank the reviewer for these very positive and constructive comments. We've adapted our manuscript in response to these, and those of the other reviewer, to use more acknowledged terminology to enhance clear communication. We are particularly pleased our work was accessible to someone from outside the 'niche' world of paediatric oncology.
The elements raised by Reviewer 2:
Comments to the Author This is a really interesting article which I think could make a worthwhile contribution to the literature on patient and public involvement in health and social care as well as paediatric oncology. As the former is my area of expertise rather than the latter the following comments are focused on this submission as an article on PPI I think the article needs to locate this work in relation to the PPI literature and particularly the literature on children and young people's involvement e.g. why the research team wanted to do PPI, evidence on benefits and good practice. Some reflection on the cons as well as the pros of the approach taken and emerging learning would be helpful. how the PPI group informed the trial plans Language is inconsistent for those involved Response summary:
We would like to greatly thank the reviewer for their work in improving our article, providing a great selection of evidence to deepen our work and thoroughly appreciate the work we are attempting to do. We have described more critically our method, highlighting the weaknesses and suggested reasons for success, developed the background and where this advances our knowledge of PPI further, and put in a more consistent approach to 'naming' as well as expanding what actually occurred in the information sharing part of the group discussion.
